Skip to main content
OpenTrials
Completed

NCT Number: NCT01383213

Helmet Continuous Positive Airway Pressure (CPAP) Versus Oxygen Venturi in Severe Acute Respiratory Failure in Pneumonia

The purpose of this study is to compare the efficacy of CPAP application by a helmet and O2 administration by a Venturi mask in terms of achievement of criteria for endotracheal intubation during severe acute respiratory failure caused by pneumonia

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico

Milan, 20122, Italy

About this study

Pneumonia is one of the commonest causes of hospitalised acute respiratory failure with a mortality rate up to 30%.

Continuous Positive Airway Pressure (CPAP) has ben recently proved to be effective. To date, however, no prospective randomised study has been published on the comparison between CPAP and O2 administration by Venturi mask for the treatment of severe acute respiratory failure in patients with pneumonia. .

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • men and women of any ethnic group;
  • age ≥18 years;
  • dyspnoea at rest with respiratory rate (RR) ≥30 breath/min or sign of respiratory distress
  • PaO2/FiO2 ratio≤250 evaluated during oxygen therapy supplied at least 1 hour through a Venturi mask with FiO2 ≥0,50
  • diagnosis of pneumonia as unique cause of severe acute respiratory failure
  • informed consent from each patient or from the closest relative in case of the patient's incapacity to give it

Exclusion criteria

  • diagnosis of other causes of severe acute respiratory failure
  • unstable angina or acute myocardial infarction;
  • acute respiratory acidosis with pH <7,35 and PaCO2 >45 mmHg;
  • systolic BP <90 mmHg despite fluid resuscitation or vasopressors;
  • severe arrhythmias;
  • convulsions;
  • degree of consciousness, Kelly score>3;
  • swallowing disturbance with increasing risk of aspiration pneumonia;
  • inability to protect the airway;
  • recent facial trauma or burn;
  • non-collaborative patient;
  • presence of open wounds (head, thorax, abdomen);
  • respiratory arrest or need of intubation;
  • pregnancy or suspect of pregnancy

Treatment and study plan

Oxygen therapy

Other

patient in group oxygen therapy by Venturi Mask will be treated with oxygen until reaching clinical stability, or criteria of endotracheal intubation

Helmet CPAP

Other

patient in group CPAP will be treated with CPAP until reaching clinical stability, or criteria of endotracheal intubation

Primary outcomes

  1. to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for Endotracheal Intubation.

    Time frame: the reaching of the following endotracheal intubation criteria maintained for at least one hour:

    Endotracheale intubation criteria:≥1 among the major criteria or ≥2 among the minor criteria MAJOR CRITERIA:Respiratory arrest;Respiratory pauses with unconsciousness;Severe hemodynamic instability; Need of sedation MINOR CRITERIA:Reduction ≥ 30% of basal PaO2/FiO2; Increasing of 20% PaCO2 if basal PaCO2 is≥40mmHg; Worsening of alertness;Distress;SpO2<90%;Exhaustion.

    The reaching of these criteria does not automatically imply the actual intubation of the patient, since this decision will depend on the treating physician.

Secondary outcomes

  1. to Compare the Efficacy of the Two Treatments in Terms of In-hospital Mortality

    Time frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

    The secondary endpoint of this study will be evaluated, if appropriate, on 3 subpopulations composed of:

    • CPAP: patients randomised to CPAP treatment who have changed treatment only after the reaching of the primary endpoint
    • Control: patients randomised to Venturi mask treatment
    • Mixed: patients who, after the treatment with Venturi mask, have needed to be treated with non-invasive CPAP

Sponsors and collaborators

Lead sponsor

University of Milan

Other

Registry information

Official study title

A Prospective, Randomized, Controlled Trial to Evaluate the Efficacy of CPAP Delivered by Helmet in Comparison With Oxygen Therapy by Venturi Mask in Severe Acute Respiratory Failure Caused by Pneumonia

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Jun 28, 2011
Registry last updated
Feb 14, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.